Ramesh Kashi
15Patents
6h-index
32Co-inventors
62Inventor score
Filing activity: Feb 22, 2000 → May 1, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6586573B1 | Albumin-free Factor VIII formulations | Emerging Cross-Sectional Technologies | 67 | Expired |
| US7087723B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 37 | Expired |
| US7247707B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 18 | Expired |
| US8541002B2 | Vaccine for treatment and prevention of herpes simplex virus infection | Chemistry; Metallurgy | 13 | Active |
| US9649383B2 | Liquid formulations for TNFR:Fc fusion proteins | Chemistry; Metallurgy | 7 | Active |
| US8058226B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 7 | Active |
| US8263748B2 | Lyophilized formulations of engineered anti-IL-23p19 antibodies | Emerging Cross-Sectional Technologies | 5 | Active |
| US8372800B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 4 | Active |
| US9803010B2 | Crystalline anti-human IL-23p19 antibodies | Chemistry; Metallurgy | 3 | Active |
| US11633476B2 | Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US8765665B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US9669076B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 1 | Active |
| US11014986B2 | Crystals of anti-human PD-1 monoclonal antibodies | Chemistry; Metallurgy | 1 | Active |
| US9352027B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 1 | Active |
| US7625584B2 | Method of complexing a protein by the use of a dispersed system and proteins thereof | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.